$TMDX

2 Stocks Down 28% and 34% to Buy and Hold

TransMedics Group (TMDX) and SoFi Technologies (SOFI) have seen significant stock declines. TMDX's revenue grew 21% YoY to $189.9M, but profits fell 52%. SOFI's revenue rose 43% to $1.2B, with net income up 61%. Both face near-term challenges but are seen as long-term opportunities.

Original reporting
Published Sep 15, 2026, 3:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 3:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2 Stocks Down 28% and 34% to Buy and Hold — source image
Decision brief

The 30-second read

$TMDXBearishMed
01

Why it matters

Earnings releases provide fresh data for valuation models; investors should reassess margin expectations for TMDX and guidance assumptions for SOFI.

02

Market read

Both stocks have underperformed sharply over the past year; the new earnings data may influence short‑term positioning.

03

What to watch

TransMedics' upcoming kidney‑transplant approval and SoFi's cryptocurrency‑trading reinstatement may unlock future upside.

Relevance 7/10Novelty 7/10Timing: post‑earnings release

Background

The article reviews recent Q2 earnings for TransMedics Group (TMDX) and SoFi Technologies (SOFI), noting revenue growth, earnings miss, and forward outlook.

Company-level read

Ticker impact

$TMDXBearishMedium confidence
Context

TransMedics Group reported Q2 revenue of $189.9M, up 21% YoY, and adjusted EPS of $0.44, 52% lower YoY.

Expected impact

Potential short-term downside as investors digest lower profitability.

Evidence & confidence

Revenue growth is solid, but the steep EPS decline suggests margin pressure.

$SOFINeutralMedium confidence
Context

SoFi posted Q2 revenue of $1.2B (+43% YoY) and net income of $156.6M (+61% YoY), but guidance fell short of estimates.

Expected impact

Stock may see modest volatility as investors weigh growth versus guidance.

Evidence & confidence

Revenue and earnings beat expectations, but high forward PE and weak outlook limit upside.

Market effects

Both companies highlight ongoing volatility in the biotech and fintech sectors as investors balance growth with profitability.

U.S. market sentiment may be tempered by these earnings, especially in the health‑tech and digital banking spaces.

Limited to U.S. investors; no direct global macro impact.

Counterpoint

Despite earnings misses, the long‑term addressable markets for organ‑preservation tech and digital banking could support a rebound.

Key entities

  • TransMedics Group

    Developer of Organ Care System for organ preservation.

  • SoFi Technologies

    Fintech platform offering lending, banking, and crypto services.

Related articles

$SOFIMed

SoFi Technologies Put Prudential Life Insurance in Its App for 15 Million-Plus Members. Here’s Why It Matters for a 25% to 30% Return Target

SoFi Technologies (SOFI) and Prudential Financial (PRU) announced a partnership allowing 15M+ SoFi members to buy Prudential's SimplyTerm life insurance via the SoFi app. SOFI shares rose 1.5% on the news. SOFI aims for 25-30% return targets, with CFO Chris Lapointe emphasizing fee-based revenue growth. Analysts have a mid-target price of ~$34 for SOFI, implying a 128% total return potential.

$SOFIHigh

SoFi Begins Rolling Out Interest-Earning Tokenized Deposits

SoFi has started rolling out interest-earning tokenized deposits (SOFIE) to its crypto members, offering a 4.40% APY. SOFIE tokens are FDIC-insured and can be converted to SoFiUSD stablecoins for crypto purchases or transfers. SoFi CEO Anthony Noto highlighted the benefits of combining bank deposit protections with digital asset utility. The company previously announced plans to integrate stablecoin utility across its ecosystem, with $300 million of SoFiUSD in circulation by Q2 2023.

$SOFIMed

SoFi targets idle crypto cash with interest-bearing tokenized deposit

SoFi Technologies launched a 'tokenized deposit' product offering 4.4% annual interest on cash for crypto purchases, insured by the FDIC. CEO Anthony Noto aims to capture idle crypto funds. The product competes with non-bank crypto firms, following regulatory changes limiting stablecoin interest. SoFi Earn allows direct crypto purchases or transfers. Traditional banks are developing crypto products, with a group including Goldman Sachs planning a dollar-pegged cryptocurrency by 2027.

$SOFIMed

SOFI Stock Draws Bullish Calls As Stablecoin Bet Scales

SoFi Technologies (SOFI) stock rose 3.07% after reporting record Q2 2026 revenue of $1.2B and net income of $157M. The company is expanding into crypto payments with its SoFiUSD stablecoin, partnering with Mastercard and Orbi. Analysts have mixed views, with StoneX setting a $25 target and others trimming targets to $15-$17.50. SOFI's stock has declined 40% YTD but shows signs of consolidation.

$SOFIMed

SOFI Stock Draws Bullish Calls As Stablecoin Deal Hits Mastercard

SoFi Technologies Inc. (SOFI) shares rose 2.94% after reporting Q2 2026 record revenue of $1.2B and net income of $157M, with member growth up 35% YoY. The company's stablecoin, SoFiUSD, is now live on Mastercard's network, potentially lowering costs and speeding up clearing. Analysts have mixed views, with StoneX initiating a Buy rating and $25 target, while Goldman Sachs and TD Cowen remain cautious.